The new Twitter logo rebranded as X, is pictured in Paris on July 24, 2023, on the account of it's owner Elon Musk, after he changed his profile picture late on July 23, 2023, to the company's new ...
Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver disease drug Ocaliva is under serious threat. Looking to assess whether Ocaliva ...
A treatment for non-alcoholic steatohepatitis may finally be around the corner—and contender Intercept Pharmaceuticals hopes it won’t disappoint for a second time. Intercept’s obeticholic acid has ...
It looks like Intercept Pharmaceuticals’ Ocaliva still has a tough road ahead in nonalcoholic steatohepatitis (NASH) after a panel of FDA advisers voiced concerns with the company's application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results